A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

Cited by (1,000)

Items 101–200 of 1,000

1. Centella asiatica: Phytochemistry and mechanisms of neuroprotection and cognitive enhancement
   Gray, Nora E., Alcazar Magana, Armando, Lak, Parnian, Wright, Kirsten M., Quinn, Joseph, Stevens, Jan F., Maier, Claudia S., Soumyanath, Amala · 2018 · Phytochemistry Reviews
2. Is oxidative damage the fundamental pathogenic mechanism of Alzheimer’s and other neurodegenerative diseases?
   George L. Perry, Akihiko Nunomura, Keisuke Hirai, Xiongwei Zhu, M D Fernndez Prez, Jesús Ávila, Rudolph J. Castellani, Craig Atwood, Gjumrakch Aliev, Lawrence M. Sayre et al. · 2002 · Free Radical Biology and Medicine
3. Inhibition of Amyloid β Protein Aggregation and Neurotoxicity by Rifampicin
   Takami Tomiyama, Akira Shoji, Ken-ichiro Kataoka, Yorimasa Suwa, Satoshi Asano, Hideshi Kaneko, Noriaki Endo · 1996 · Journal of Biological Chemistry
4. Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β
   Craig Atwood, Mark E. Obrenovich, Tianbing Liu, Hsien Chan, George L. Perry, Mark A. Smith, Ralph Nigel Martins · 2003 · Brain Research Reviews
5. Alzheimer disease, the two-hit hypothesis: An update
   Xiongwei Zhu, Hyoung‐gon Lee, George L. Perry, Mark A. Smith · 2006 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
6. Microglia enhance β‐amyloid peptide‐induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species
   Liya Qin, Yuxin Liu, Cynthia L. Cooper, Bin Liu, Belinda C. Wilson, Jau‐Shyong Hong · 2002 · Journal of Neurochemistry
7. Copper and Oxidative Stress in the Pathogenesis of Alzheimer’s Disease
   Gözde Eskici, Paul H. Axelsen · 2012 · Biochemistry
8. Neuroprotective effects of green and black teas and their catechin gallate esters against β‐amyloid‐induced toxicity
   Stéphane Bastianetto, Zhixing Yao, Vassilios Papadopoulos, Rémi Quirion · 2005 · European Journal of Neuroscience
9. Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system
   Gianni Benzi, Antonio Moretti · 1995 · Free Radical Biology and Medicine
10. Deciphering the astrocyte reaction in Alzheimer's disease
    Perez-Nievas, Beatriz G., Serrano-Pozo, Alberto · 2018 · Frontiers in Aging Neuroscience
11. Computational strategies for predicting free radical scavengers' protection against oxidative stress: Where are we and what might follow?
    Annia Galano, Juan Raúl Alvarez-Idaboy · 2018 · International Journal of Quantum Chemistry
12. The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer’s and Parkinson’s diseases1,2 11Guest Editors: Mark A. Smith and George Perry 22This article is part of a series of reviews on “Causes and Consequences of Oxidative Stress in Alzheimer’s Disease.” The full list of papers may be found on the homepage of the journal.
    Benoit I. Giasson, Harry Ischiropoulos, Virginia M.‐Y. Lee, John Q. Trojanowski · 2002 · Free Radical Biology and Medicine
13. Redox Chemistry of Copper–Amyloid‐β: The Generation of Hydroxyl Radical in the Presence of Ascorbate is Linked to Redox‐Potentials and Aggregation State
    Luc Guilloreau, Sarah Combalbert, Alix Sournia‐Saquet, Honoré Mazarguil, Peter Faller · 2007 · ChemBioChem
14. The Lipid Peroxidation Product, 4‐Hydroxy‐2‐trans‐Nonenal, Alters the Conformation of Cortical Synaptosomal Membrane Proteins
    Subramaniam, Ram, Roediger, Fred, Jordan, Brad, Mattson, Mark P., Keller, Jeffrey N., Waeg, Georg, Butterfield, D. Allan · 1997 · Journal of Neurochemistry
15. Role of Estrogen Replacement Therapy in Memory Enhancement and the Prevention of Neuronal Loss Associated With Alzheimer’s Disease
    James W. Simpkins, Pattie S. Green, Kelly E. Gridley, Meharvan Singh, NancyEllen C de Fiebre, Gopal Rajakumar · 1997 · The American Journal of Medicine
16. Vitamin E and Alzheimer disease: the basis for additional clinical trials
    Michael Grundman · 2000 · American Journal of Clinical Nutrition
17. Specific Domains of β-Amyloid from Alzheimer Plaque Elicit Neuron Killing in Human Microglia
    Dana Giulian, Lanny J. Haverkamp, Jiaqi Yu, W.L. Karshin, Donald Tom, Jun Li, Joel B. Kirkpatrick, Yu‐Min Kuo, Alex E. Roher · 1996 · Journal of Neuroscience
18. A detailed analysis of hydrogen peroxide-induced cell death in primary neuronal culture
    Edward R. Whittemore, Deryk T. Loo, John A. Watt, C.W. Cotmans · 1995 · Neuroscience
19. Formation of hydrogen peroxide and hydroxyl radicals from Aβ and α-synuclein as a possible mechanism of cell death in Alzheimer’s disease and Parkinson’s disease
    Brian J. Tabner, Stuart Turnbull, Omar M. A. El‐Agnaf, David Allsop · 2002 · Free Radical Biology and Medicine
20. Astrocyte energy and neurotransmitter metabolism in Alzheimer’s disease: Integration of the glutamate/GABA-glutamine cycle
    Jens Velde Andersen, Arne Schousboe, Alexei Verkhratsky · 2022 · Progress in Neurobiology
21. β-Amyloid Fibrils Activate Parallel Mitogen-Activated Protein Kinase Pathways in Microglia and THP1 Monocytes
    Douglas R. McDonald, Maria E. Bamberger, Colin Kelly Combs, Gary E. Landreth · 1998 · Journal of Neuroscience
22. Amyloid β interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease
    Lorenzo, Alfredo, Yuan, Menglan, Zhang, Zhuohua, Paganetti, Paolo A., Sturchler-Pierrat, Christine, Staufenbiel, Matthias, Mautino, Jorge, Vigo, Francisco Sol, Sommer, Bernd, Yankner, Bruce A. · 2000 · Nature Neuroscience
23. BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells.
    Ida Giardino, Diane Edelstein, M. Brownlee · 1996 · Journal of Clinical Investigation
24. Aggregated Amyloid-β Protein Induces Cortical Neuronal Apoptosis and Concomitant “Apoptotic” Pattern of Gene Induction
    Steven Estus, H. Michael Tucker, Corlia van Rooyen, Sarah Wright, Elizabeth F. Brigham, Mark D. Wogulis, Russell E. Rydel · 1997 · Journal of Neuroscience
25. Reduction in mitochondrial superoxide dismutase modulates Alzheimer’s disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice
    Esposito, Luke, Raber, Jacob, Kekonius, Lisa, Yan, Fengrong, Yu, Giu-Qiu, Bien-Ly, Nga, Puoliväli, Jukka, Scearce-Levie, Kimberly, Masliah, Eliezer, Mucke, Lennart · 2006 · The Journal of Neuroscience
26. The cause of neuronal degeneration in Alzheimer’s disease
    Vickers, J · 2000 · Progress in Neurobiology
27. Redox signalling and the control of cell growth and death
    Garth Powis, Margaret M. Briehl, John E. Oblong · 1995 · Pharmacology & Therapeutics
28. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment
    Francesca Mangialasche, Maria Cristina Polidori, Roberto Monastero, Sara Ercolani, Cecilia Camarda, Roberta Cecchetti, Patrizia Mecocci · 2009 · Ageing Research Reviews
29. Mitotic signaling by β‐amyloid causes neuronal death
    Agata Copani, Fabrizio Condorelli, A. CARUSO, Carlo Vancheri, Arturo Sala, A. M. Giuffrida Stella, Pier Luigi Canonico, Ferdinando Nicoletti, Maria Angela Sortino · 1999 · The FASEB Journal
30. Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management
    Baljinder Singh, Candace Minhthu Day, Sadikalmahdi Abdella, Sanjay Garg · 2024 · Journal of Controlled Release
31. Mitochondrial Dysfunction: Common Final Pathway in Brain Aging and Alzheimer’s Disease—Therapeutic Aspects
    Müller, Walter E., Eckert, Anne, Kurz, Christopher, Eckert, Gunter Peter, Leuner, Kristina · 2010 · Molecular Neurobiology
32. Apoptosis Signal-Regulating Kinase 1 in Stress and Immune Response
    Kohsuke Takeda, Takuya Noguchi, Isao Naguro, Hidenori Ichijo · 2007 · The Annual Review of Pharmacology and Toxicology
33. Downregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neurons
    Subbiah Pugazhenthi, Maorong Wang, Serena T. Pham, Chun‐I Sze, Christopher B. Eckman · 2011 · Molecular Neurodegeneration
34. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer’s disease is related to the apolipoprotein E genotype
    Charles Ramassamy, Diana A. Averill‐Bates, Uwe Beffert, Stéphane Bastianetto, Louise Théroux, Suzanne Lussier‐Cacan, Jeffrey S. Cohn, Yves Christen, Jean Davignon, Rémi Quirion et al. · 1999 · Free Radical Biology and Medicine
35. Pathophysiological Roles of ASK1-MAP Kinase Signaling Pathways
    Hiroaki Nagai, Takuya Noguchi, Kohsuke Takeda, Hidenori Ichijo · 2007 · BMB Reports
36. An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease
    Miguel A. Pappolla, Yau‐Jan Chyan, Burkhard Pöeggeler, Blas Frangione, Glen L. Wilson, Jorge A. Ghiso, Russel Joseph Reiter · 2000 · Journal of Neural Transmission
37. Mitochondrial permeability transition pore in Alzheimer's disease: Cyclophilin D and amyloid beta
    Heng Du, Shirley ShiDu Yan · 2009 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
38. Role of melatonin in neurodegenerative diseases
    Vamshek J. Srinivasan, Seithikurippu Ratnas Pandi-Perumal, Georges J. M. Maestroni, Ana Isabel Esquifino, Rüdiger Hardeland, Daniel Pedro Cardinali · 2005 · Neurotoxicity Research
39. Free radical oxidation of brain proteins in accelerated senescence and its modulation by N -tert-butyl-α-phenylnitrone
    David Allan Butterfield, Beverly J. Howard, Servet M. Yatin, Kerry L. Allen, John M. Carney · 1997 · Proceedings of the National Academy of Sciences
40. Melatonin in Alzheimer's disease and other neurodegenerative disorders
    Vamshek J. Srinivasan, Seithikurippu Ratnas Pandi-Perumal, Daniel Pedro Cardinali, Burkhard Pöeggeler, Rüdiger Hardeland · 2006 · Behavioral and Brain Functions
41. Reactive oxygen species and Alzheimer's disease
    Gerd Multhaup, Thomas Ruppert, Andrea Schlicksupp, Lars Hesse, Dirk Beher, Colin Louis Masters, Konrad Beyreuther · 1997 · Biochemical Pharmacology
42. Gradual Alteration of Mitochondrial Structure and Function by β-Amyloids: Importance of Membrane Viscosity Changes, Energy Deprivation, Reactive Oxygen Species Production, and Cytochrome c Release
    A. M. Aleardi, G. Benard, Olivier Augereau, Monique Malgat, Jean-Claude Talbot, Jean‐Pierre Mazat, Thierry Letellier, J. Dachary-Prigent, Giancarlo Solaini, Rodrigue Rossignol · 2005 · Journal of Bioenergetics and Biomembranes
43. Why do mitochondria synthesize fatty acids? Evidence for involvement in lipoic acid production
    Hajime Wada, David K. Shintani, John B. Ohlrogge · 1997 · Proceedings of the National Academy of Sciences
44. Melatonin protects neurons from singlet oxygen‐induced apoptosis
    Cinzia M. Cagnoli, Çağla Atabay, Elena Kharlamova, Hari Manev · 1995 · Journal of Pineal Research
45. Amyloid peptides and proteins in review
    Rosemary S. Harrison, Philip C. Sharpe, Yogendra Singh, David P. Fairlie · 2007 · Springer eBooks
46. beta-Amyloid toxicity in organotypic hippocampal cultures: Protection by EUK-8, a synthetic catalytic free radical scavenger
    Bruce, A J, Malfroy, B, Baudry, M · 1996 · Proceedings of the National Academy of Sciences
47. Oxidative Stress and Neurodegenerative Disorders
    Albert Y. Sun, Yongmei Chen · 1998 · Journal of Biomedical Science
48. Familial Amyloid Polyneuropathy: Receptor for Advanced Glycation End Products-Dependent Triggering of Neuronal Inflammatory and Apoptotic Pathways
    Sousa, Mónica Mendes, Du Yan, Shi, Fernandes, Rui, Guimarães, António, Stern, David, Saraiva, Maria João · 2001 · The Journal of Neuroscience
49. Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease
    Christian Behl · 1997 · Cell and Tissue Research
50. Mercury Induces Cell Cytotoxicity and Oxidative Stress and Increases β‐Amyloid Secretion and Tau Phosphorylation in SHSY5Y Neuroblastoma Cells
    Gianfranco Olivieri, Ch. Brack, Franz Müller-Spahn, Hannes Benedikt Stähelin, Martin Herrmann i, Patricia Renard, Manfred Brockhaus, C. Hock · 2000 · Journal of Neurochemistry
51. Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons.
    Jeremiah F. Kelly, Katsutoshi Furukawa, Steven W. Barger, Mohan Rengen, Robert J. Mark, Emmanuelle M. Blanc, G. S. Roth, Mark P. Mattson · 1996 · Proceedings of the National Academy of Sciences
52. Converging Pathogenic Mechanisms in Vascular and Neurodegenerative Dementia
    Costantino Iadecola, Philip B. Gorelick · 2003 · Stroke
53. Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease
    Cioffi, Federica, Adam, Rayan Hassan Ibrahim, Broersen, Kerensa · 2019 · Journal of Alzheimer s Disease
54. Oxidative stress and Alzheimer’s disease: dietary polyphenols as potential therapeutic agents
    Altaf S. Darvesh, Richard T. Carroll, Anupam Bishayee, Werner J. Geldenhuys, Cornelis J. Van der Schyf · 2010 · Expert Review of Neurotherapeutics
55. Diseases related to oxygen-derived free radicals.
    J A Knight · 1995 · PubMed
56. Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: Relevance to Alzheimer's disease
    Opii, Wycliffe O., Joshi, Gururaj, Head, Elizabeth, Milgram, N. William, Muggenburg, Bruce A., Klein, Jon B., Pierce, William M., Cotman, Carl W., Butterfield, D. Allan · 2008 · Neurobiology of Aging
57. Aβ-peptides enhance vasoconstriction in cerebral circulation
    Niwa, Kiyoshi, Porter, Valerie A., Kazama, Ken, Cornfield, David, Carlson, George A., Iadecola, Costantino · 2001 · American Journal of Physiology-Heart and Circulatory Physiology
58. Calcium dysregulation in Alzheimer's disease
    Łukasz Bojarski, Jochen Wolfgang Herms, Jacek Kuźnicki · 2007 · Neurochemistry International
59. Free Radical Reactions of Methionine in Peptides: Mechanisms Relevant to β-Amyloid Oxidation and Alzheimer's Disease
    Christian Schöneich, Dariusz Pogocki, Gordon L. Hug, Krzysztof Bobrowski · 2003 · Journal of the American Chemical Society
60. Adverse Stress, Hippocampal Networks, and Alzheimer’s Disease
    Sarah M. Rothman, Mark P. Mattson · 2009 · NeuroMolecular Medicine
61. Mitochondrial Dysfunction: The First Domino in Brain Aging and Alzheimer's Disease?
    Kristina Leuner, Susanne Hauptmann, Reham Mahmoud Abdel-Kader, Isabel Scherping, Uta Keil, Joanna Benigna Strosznajder, Anne Eckert, Walter E. Müller · 2007 · Antioxidants and Redox Signaling
62. Oxidative Insults Are Associated with Apolipoprotein E Genotype in Alzheimer's Disease Brain
    Charles Ramassamy, Diana A. Averill‐Bates, Uwe Beffert, Louise Théroux, Suzanne Lussier‐Cacan, Jeffrey S. Cohn, Yves Christen, Alain René Schoofs, Jean Davignon, Judes Poirier · 2000 · Neurobiology of Disease
63. Antioxidant peptides, the guardian of life from oxidative stress
    Yiyun Zhu, Kang Wang, Xinyi Jia, Caili Fu, Haining Yu, Yipeng Wang · 2023 · Medicinal Research Reviews
64. β-Amyloid peptides as direct cholinergic neuromodulators: a missing link?
    Daniel S. Auld, Satyabrata Kar, Rémi Quirion · 1998 · Trends in Neurosciences
65. Prion Protein Peptides Induce .alpha.-Helix to .beta.-Sheet Conformational Transitions
    Jack T Nguyen, M. A. Baldwin, Fred E. Cohen, Stanley B. Prusiner · 1995 · Biochemistry
66. Abeta, oxidative stress in Alzheimer disease: Evidence based on proteomics studies
    Aaron M. Swomley, Sarah Förster, Jeriel T. R. Keeney, Judy C. Triplett, Zhaoshu Zhang, Rukhsana Sultana A, David Allan Butterfield · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
67. The contrasting roles of ICE family proteases and interleukin-1beta in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation.
    Carol M. Troy, Leonidas Stefanis, Alain Prochiantz, LA Greene, Michael L. Shelanski · 1996 · Proceedings of the National Academy of Sciences
68. Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium
    Mark P. Mattson, Yadong Goodman · 1995 · Brain Research
69. Oxidation of Cholesterol by Amyloid Precursor Protein and β-Amyloid Peptide
    Thomas J. Nelson, Daniel L. Alkon · 2005 · Journal of Biological Chemistry
70. Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease
    George L. Perry, Rudy J. Castellani, Keisuke Hirai, Mark A. Smith · 1998 · Journal of Alzheimer s Disease
71. Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders
    Salvadores, Natalia, Sanhueza, Mario, Manque, Patricio, Court, Felipe A. · 2017 · Frontiers in Neuroscience
72. The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from β-amyloid-induced cell death by inhibiting the formation of β-amyloid-derived diffusible neurotoxic ligands
    Zhixing Yao, Katy Drieu, Vassilios Papadopoulos · 2001 · Brain Research
73. Dysregulation of Cellular Calcium Homeostasis in Alzheimer's Disease: Bad Genes and Bad Habits
    Mark P. Mattson, Sic L. Chan · 2001 · Journal of Molecular Neuroscience
74. The role of beta amyloid in Alzheimer?s disease: still a cause of everything or the only one who got caught?
    Giuseppe Verdile · 2004 · Pharmacological Research
75. Chronic stress as a risk factor for Alzheimer’s disease
    Alberto Machado, Antonio J. Herrera, Rocío M. de Pablos, Ana M. Espinosa‐Oliva, Manuel Sarmiento Soto, Antonio Ayala, Jose Luis Venero, Martiniano Santiago, Ruth F. Villarán, María José Delgado‐Cortés et al. · 2014 · Reviews in the Neurosciences
76. Amyloid-β: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer’s disease
    Anatol Kontush · 2001 · Free Radical Biology and Medicine
77. Interaction of the Receptor for Advanced Glycation End Products (RAGE) with Transthyretin Triggers Nuclear Transcription Factor kB (NF-kB) Activation
    Mónica Mendes Sousa, Shi Du Yan, David M. Stern, Maria João Saraiva · 2000 · Laboratory Investigation
78. Neurotoxic Mechanisms Caused by the Alzheimer's Disease-linked Swedish Amyloid Precursor Protein Mutation
    Celio A. Marques, Uta Keil, Astrid Bonert, Barbara Steiner, Christian Haass, Walter E. Müller, Anne Eckert · 2003 · Journal of Biological Chemistry
79. Neuroprotective effects of huperzine A: New therapeutic targets for neurodegenerative disease
    Zhang, Hai Yan, Tang, Xi Can · 2006 · Trends in Pharmacological Sciences
80. Glutamate–glutamine cycling in Alzheimer's disease
    WALTON, H, DODD, P · 2007 · Neurochemistry International
81. In Vivo Imaging of Reactive Oxygen Species Specifically Associated with Thioflavine S-Positive Amyloid Plaques by Multiphoton Microscopy
    McLellan, Megan E., Kajdasz, Stephen T., Hyman, Bradley T., Bacskai, Brian J. · 2003 · The Journal of Neuroscience
82. Acteoside protects human neuroblastoma SH-SY5Y cells against β-amyloid-induced cell injury
    Hongquan Wang, Yuxia Xu, Jie Yan, Xiaoyan Zhao, Xiaobo Sun, Yanping Zhang, Jingchun Guo, Cuiqing Zhu · 2009 · Brain Research
83. Codeposition of Cystatin C with Amyloid-β Protein in the Brain of Alzheimer Disease Patients
    Efrat Levy, Magdalena Sastre, Asok R. Kumar, Gloria Gallo, Pedro Piccardo, Bernardino Francesco Ghetti, Fabrizio Tagliavini · 2001 · Journal of Neuropathology & Experimental Neurology
84. Phenolic A ring requirement for the neuroprotective effects of steroids
    Pattie S. Green, Katherine Gordon, James W. Simpkins · 1997 · The Journal of Steroid Biochemistry and Molecular Biology
85. Methionine residue 35 is important in amyloid β-peptide-associated free radical oxidative stress
    Sridhar Varadarajan, Servet M. Yatin, Jarosław Kański, Feerozeh Jahanshahi, David Allan Butterfield · 1999 · Brain Research Bulletin
86. The emerging role of glutathione in Alzheimer’s disease
    Saharan, Sumiti, Mandal, Pravat K. · 2014 · Journal of Alzheimer s Disease
87. Basic FGF attenuates amyloid β-peptide-induced oxidative stress, mitochondrial dysfunction, and impairment of Na+/K+-ATPase activity in hippocampal neurons
    Mark, Robert J, Keller, Jeffrey N, Kruman, Inna, Mattson, Mark P · 1997 · Brain Research
88. Subcellular and metabolic examination of amyloid-β peptides in Alzheimer disease pathogenesis: Evidence for Aβ25–35
    Yury G. Kaminsky, Michael W. Marlatt, Mark A. Smith, Elena A. Kosenko · 2009 · Experimental Neurology
89. Mitochondrial involvement in Alzheimer’s disease
    Eduardo Bonilla, Kurenai Tanji, Michio Hirano, Tuan Vu, Salvatore DiMauro, Eric A. Schon · 1999 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
90. Catecholamines Potentiate Amyloid β-Peptide Neurotoxicity: Involvement of Oxidative Stress, Mitochondrial Dysfunction, and Perturbed Calcium Homeostasis
    Weiming Fu, Hong Luo, Sampath Parthasarathy, Mark P. Mattson · 1998 · Neurobiology of Disease
91. Calcium and Neuronal Injury in Alzheimer's Disease: Contributions of β‐Amyloid Precursor Protein Mismetabolism, Free Radicals, and Metabolic Compromisea
    MATTSON, MARK P. · 1994 · Annals of the New York Academy of Sciences
92. Free Radicals in Human Health and Disease
    Umesh Chand Singh Yadav, Vibha Rani · 2014 · Springer eBooks
93. Neuronal expression of glutamine synthetase in Alzheimer’s disease indicates a profound impairment of metabolic interactions with astrocytes
    Stephen R. Robinson · 2000 · Neurochemistry International
94. Metal‐Catalyzed Disruption of Membrane Protein and Lipid Signaling in the Pathogenesis of Neurodegenerative Disorders
    Mark P. Mattson · 2004 · Annals of the New York Academy of Sciences
95. Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases
    Marcela Cruz-Haces, JONATHAN C. Y. TANG, Glen Acosta, Joseph Fernandez, Riyi Shi · 2017 · Translational Neurodegeneration
96. Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons.
    Jochen H.M. Prehn, Vytautas P. Bindokas, Joaquı́n Jordán, María Francisca Galindo, Ghanashyam D. Ghadge, Raymond P. Roos, Lawrence Boise, Craig B. Thompson, Stanisław Krajewski, John C. Reed et al. · 1996 · Molecular Pharmacology
97. Nanoparticle and other metal chelation therapeutics in Alzheimer disease
    Gang Liu, Matthew R. Garrett, Ping Men, Xiongwei Zhu, George L. Perry, Mark A. Smith · 2005 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
98. Amyloid fibrils from the viewpoint of protein folding
    S. Ohnishi, Kazufumi Takano · 2004 · Cellular and Molecular Life Sciences
99. Pathogenesis of cerebral amyloid angiopathy
    Annemieke A.M. Rensink, Robert M.W. de Waal, Berry P. H. Kremer, Marcel M. Verbeek · 2003 · Brain Research Reviews
100. Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer’s patients
     Cristina Cecchi, Claudia Fiorillo, Sandro Sorbi, Stefania Latorraca, Benedetta Nacmias, Silvia Bagnoli, Paolo Nassi, Gianfranco Liguri · 2002 · Free Radical Biology and Medicine